Panacea Life Expands CBD Business Into Guyana, South America

Panacea Life Sciences Holdings, Inc. PLSH, a Colorado-based manufacturing, research, and product development company in the natural health and wellness industry, announced the execution of a distribution agreement with C.A.G. Global to expand its line of “seed-to-sale” CBD products into Guyana, South America.

C.A.G. Global founder, Cort Gomes, stated “the CBD market is a new and exciting market which plays in directly with the government's vision for a greener Guyana. Our people will welcome a healthier path to wellness, and, for this reason, the CBD market will become one of the most booming markets in Guyana over the next coming years”.

Panacea will launch its full line of CBD topical and ingestible products in May 2023 through C.A.G. Global. In the country’s capital of Georgetown there are 15 large pharmacies and numerous convenience stores eager to provide Panacea products to its 300,000 citizens. As Panacea expands its reach globally, the company intends to develop relationships with countries like Guyana that are embracing hemp and unlocking the true potential of cannabinoid research for medicinal use rather than just recreational use.

“We have seen early indications of a very strong market in South America, and we are excited to have C.A.G. Global join the Panacea team,” stated Nick Cavarra, president of Panacea Life.

Because Panacea develops and manufactures all its CBD products in-house, the company can provide an array of CBD products priced in accordance with the socioeconomics of Guyana to provide its citizens with an all-natural remedy for relief of common ailments like pain, sleep deprivation and anxiety.

Photo by Jeff W on Unsplash

Related News

DEA Announces How Much Marijuana, MDMA, Psilocyn, LSD, Mescaline, 5-MeO-DMT, MDA, 2-CB Can Be Produced For Research In 2023

Panacea Life Sciences Partners With Chanelle McCoy Health For Launch Of 0% THC CBD Products